Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
27.47
+0.37 (1.37%)
At close: Apr 8, 2026, 4:00 PM EDT
27.37
-0.10 (-0.36%)
Pre-market: Apr 9, 2026, 8:44 AM EDT
Pfizer Stock Forecast
Stock Price Forecast
The 14 analysts that cover Pfizer stock have a consensus rating of "Buy" and an average price target of $28.57, which forecasts a 4.00% increase in the stock price over the next year. The lowest target is $25 and the highest is $36.
Price Target: $28.57 (+4.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pfizer stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 2 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 9 | 10 | 8 | 8 | 8 |
| Sell | 0 | 0 | 0 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 11 | 11 | 12 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $35 → $36 | Strong Buy | Maintains | $35 → $36 | +31.05% | Mar 24, 2026 |
| HSBC | HSBC | Strong Buy Maintains $29 → $32 | Strong Buy | Maintains | $29 → $32 | +16.49% | Mar 17, 2026 |
| Argus Research | Argus Research | Hold → Strong Buy Upgrades $35 | Hold → Strong Buy | Upgrades | $35 | +27.41% | Mar 2, 2026 |
| RBC Capital | RBC Capital | Sell Initiates $25 | Sell | Initiates | $25 | -8.99% | Feb 25, 2026 |
| Barclays | Barclays | Sell Initiates $25 | Sell | Initiates | $25 | -8.99% | Feb 20, 2026 |
Financial Forecast
Revenue This Year
61.84B
from 62.58B
Decreased by -1.18%
Revenue Next Year
59.63B
from 61.84B
Decreased by -3.57%
EPS This Year
2.99
from 1.36
Increased by 118.84%
EPS Next Year
2.85
from 2.99
Decreased by -4.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 65.7B | 65.8B | |||
| Avg | 61.8B | 59.6B | |||
| Low | 58.6B | 55.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.0% | 6.4% | |||
| Avg | -1.2% | -3.6% | |||
| Low | -6.4% | -9.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.33 | 3.18 | |||
| Avg | 2.99 | 2.85 | |||
| Low | 2.74 | 2.43 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 144.0% | 6.4% | |||
| Avg | 118.8% | -4.5% | |||
| Low | 101.1% | -18.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.